Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Lapsi Health launches Keikku in Europe following CE MDR Class I certification

1 September 2026 · By · Wire by Fusion42

Published

1 September 2026

Topic

opportunities

◆ Sectors

Healthtech Infrastructure

◆ Geography

Europe

◆ Source

Read at med-tech.world →

◆ Verified

Fusion42 · 1 September 2026 · Fusion42 review

Lapsi Health has launched Keikku, its clinical AI platform, in Europe following its CE MDR Class I medical device certification, enabling deployment across varied European healthcare settings with multilingual support and EHR integration.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.

◆ ◆ The Wire takeaway

Keikku's CE MDR Class I certification clears regulatory barriers, allowing you to enter the European clinical AI market with a compliant product built for local complexities like multilingualism and GDPR. This opens a clear path to scale enterprise healthcare deployments without being slowed by diverse EHR and regulatory demands.

◆ Coverage

1 source · 1 Sep 2026

◆ Related on Wire

◆ Topics

Healthtech Infrastructureclinical-aimedtechce-mdrhealthcare-softwareehr-integration